1. Synthesis, biological evaluation and molecular dynamics studies of 1,2,4-triazole clubbed Mannich bases.
- Author
-
Patel VM, Patel NB, Chan-Bacab MJ, and Rivera G
- Subjects
- Antifungal Agents chemical synthesis, Antifungal Agents chemistry, Antiprotozoal Agents chemical synthesis, Antiprotozoal Agents chemistry, Antitubercular Agents chemical synthesis, Antitubercular Agents chemistry, Bacterial Proteins chemistry, Catalytic Domain, Drug Design, Gram-Negative Bacteria drug effects, Gram-Positive Bacteria drug effects, Leishmania mexicana drug effects, Mannich Bases chemical synthesis, Mannich Bases chemistry, Microbial Sensitivity Tests, Molecular Docking Simulation, Molecular Dynamics Simulation, Oxidoreductases Acting on CH-CH Group Donors chemistry, Structure-Activity Relationship, Triazoles chemical synthesis, Triazoles chemistry, Trypanosoma cruzi drug effects, Antifungal Agents pharmacology, Antiprotozoal Agents pharmacology, Antitubercular Agents pharmacology, Mannich Bases pharmacology, Triazoles pharmacology
- Abstract
The present work highlightsthe synthesis of a newer biologically active Mannich bases contributing 4-((4-fluorobenzylidene)amino)-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol and various heterocyclic amines via N-Mannich reaction by the conventional method as well as microwave heating approach as a part of an environmentally benign synthetic protocol. All the synthesized compounds were characterized by spectral analysis and were screened for in vitro antimicrobial, antitubercular and antiprotozoal activity. The compound 4k was found to be most active respectively against S. aureus (MIC 12.5 μM) and C. albicans (MIC 100 μM). The derivative 4 g displayed potency against L.mexicana and T. cruzi with IC
50 value 1.01 and 3.33 μM better than reference drug Miltefosina and Nifurtimox. The compound 4b displayed excellent potency against M. tuberculosis (MIC 6.25 μM) in the primary screening. The computational studies revealed for that Mannich derivative (4b) showed a high affinity toward the active site of enzyme which provides a strong platform for new structure-based design efforts. The Lipinski's parameters showed good drug-likeness properties and can be developed as an oral drug candidate., (Copyright © 2018 Elsevier Ltd. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF